Resources

As part of the Strengthening Vaccine-Preventable Disease Surveillance System Assessment, 23 countries responded to the landscape survey, which included 86 questions, including a mix of yes or no and multiple-choice questions, making them primarily quantitative. A smaller number of open-ended questions captured more qualitative or contextual information. Survey responses were mapped to indicators within specific sub-domains of a maturity model, with scores calculated for each sub-domain. These were then averaged to generate an overall maturity score for each of the eight main domains.

Supporting governments and partners across Africa to enhance surveillance systems for vaccine-preventable diseases. Through a regional assessment initiative, we evaluated digital readiness, system capacity, and data quality to identify opportunities to strengthen surveillance for better disease detection, reporting, and response.

Country- and Community-Led Scale-Up of Accessible, Integrated, and Family-Centered EVT Plus Services for a Healthy Start (SAFEStart+)While childhood survival rates have significantly improved in the past decade, every year, approximately five million children die before their fifth birthday—almost half are newborns in their first month of life. Vertical transmission of HIV, syphilis, hepatitis B, and Chagas disease is a leading cause of preventable stillbirth and child mortality. Timely diagnosis and treatment of these infections are critical to protect the health and well-being of women, infants, and young children.Through partnership and funding from Unitaid, PATH and the project’s co-leads, the International Community of Women living with HIV Eastern Africa and the World Hepatitis Alliance, are leading a four-year project designed for maximum reach and impact: SAFEStart+. This project is accelerating demand and adoption of evidence-based approaches and integrated delivery strategies to eliminate vertical transmission of HIV, syphilis, hepatitis B, and Chagas disease.SAFEStart+ is supporting countries and communities to design and scale integrated, people-centered services that meet local needs. This includes expanding access to new diagnostics that can detect multiple infections with a single test and reinforcing antenatal care services to deliver preventive treatment when it matters most.

This factsheet focuses on the development of BABE—a low-cost bubble continuous positive airway pressure (bCPAP) device with oxygen blenders to help babies with respiratory distress syndrome. BABE is designed to provide bCPAP therapy to preterm newborns without requiring a power source (i.e., electricity or battery) or medical-grade compressed air.

PATH’s Center for Advocacy and Policy convened a two-part webinar series to examine how Africa can sustain and accelerate maternal, newborn, and child health (MNCH) progress amid shrinking global aid.Part 1: MNCH Financing in Africa – This session explored the shifting aid dynamics shaping MNCH and highlighted the urgent need for sustainable funding, collective action, and innovative partnerships.Part 2: Accelerating Progress Despite Declining Aid – The second session examined what shrinking development assistance means for MNCH in Africa and how countries can adapt. Speakers emphasized the importance of regional leadership, domestic resource mobilization, and innovative partnerships to ensure health systems remain strong and resilient in the face of declining aid.Watch the recordings below to learn more about the evolving aid landscape and strategies to secure a healthier future for women and children in Africa.